** Shares of Archer Materials AXE.AX rise as much as 13.3% to A$0.34, highest level since February 26
** Semiconductor technology company enters partnership with Hylid Diagnostics to develop an at-home testing device for chronic kidney disease as part of its Biochip project
** About 279,150 shares change hands by 0057 GMT, 1.3 times the 30-day average volume of shares
** Stock down 48.3% this year, as of last close
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。